NINGBO INNO PHARMCHEM CO.,LTD. is committed to advancing the pharmaceutical industry through the reliable provision of high-quality chemical intermediates. Today, we shed light on 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide Hydrochloride (CAS 256499-19-1), a fundamental precursor in the synthesis of Riociguat. Riociguat is a vital medication for individuals diagnosed with pulmonary hypertension, a serious condition affecting the pulmonary arteries.

Riociguat's mechanism of action involves the direct stimulation of soluble guanylate cyclase (sGC), which leads to vasodilation and a reduction in pulmonary artery pressure. The precise and consistent production of Riociguat hinges on the quality of its chemical intermediates. Our 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide Hydrochloride, characterized by its u226598.0% assay and white solid appearance, is manufactured to the highest standards, facilitating robust Riociguat intermediate synthesis protocols.

As a leading pharmaceutical intermediate manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. understands the critical nature of a dependable supply chain. When businesses opt to buy 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride, they are securing a critical component for their manufacturing processes. Our expertise in the intricate chemical synthesis of Riociguat ensures that our clients receive materials that meet their exacting requirements.

The field of pyrazolo[3,4-b]pyridine derivatives is rich with potential for developing new pharmaceutical agents. Our intermediate is a prime example of a precisely engineered molecule crucial for a specific therapeutic application. The complex nature of Riociguat intermediate synthesis emphasizes the importance of specialized chemical manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. in the drug development lifecycle.

NINGBO INNO PHARMCHEM CO.,LTD. plays an integral role in the pharmaceutical ecosystem by supplying essential chemical building blocks. Our consistent provision of high-quality CAS 256499-19-1 supports the production of critical treatments for pulmonary hypertension. We are dedicated to fostering partnerships that drive innovation and improve patient outcomes.

In conclusion, 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide Hydrochloride is an indispensable intermediate for the synthesis of Riociguat, directly contributing to the effective management of pulmonary hypertension. NINGBO INNO PHARMCHEM CO.,LTD. is proud to be a key supplier in this vital area of pharmaceutical advancement.